TCL Archive Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting April 29, 2011
TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program October 25, 1985
TCL Archive NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs June 20, 1975
TCL Archive Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall June 5, 2009
